Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein

Journal of Virology

Volumn 74, Issue 1, 2000, Pages 281-294

  Rinaudo, Daniela ^a   Lamartina, Stefania ^a   Roscilli, Giuseppe ^a   Ciliberto, Gennaro ^a   Toniatti, Carlo ^a  

^a IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; HELICASE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL CULTURE; CHROMOSOME 19; DELETION MUTANT; GENE INSERTION; GENE LOCUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION;

EID: 0033987080     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.1.281-294.2000     Document Type: Article

References (69)

1. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1995. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
2. Balagué, C., M. Kalla, and W.-W. Zhang. 1997. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71:3299-3306.
3. Baulieu, E. E. 1985. RU486: an antiprogestin steroid with contragestive activity in women, p. 1-25. In E. E. Baulieu and J. Segal (ed.), The antiprogestin steroid RU486 and human fertility control. Plenum Press, New York, N.Y.
4. Berns, K. I., and R. M. Linden. 1995. The cryptic life stile of adeno-associated virus. Bioessays 17:237-245.
5. Cadepond, F., A. Ulmann, and E.-E. Baulieu. 1997. RU486 (mifepristone): mechanisms of action and clinical use. Annu. Rev. Med. 48:129-156.
6. Chesnut, J. D., A. R. Baytan, M. Russell, M-P. Chang, A. Bernard, I. H. Maxwell, and J. P. Hoeffler. 1996. Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibody. J. Immunol. Methods 193:17-27.
7. Chiorini, J. A., S. M. Wiener, R. A. Owens, S. R. M. Kyöstiö, R. M. Kotin, and B. Safer. 1994. Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats. J. Virol. 68:7448-7457.
8. Chiorini, J. A., L. Yang, R. M. Kotin, and B. Safer. 1995. Determination of adeno-associated virus Rep68 and Rep78 binding sites by random sequence oligonucleotide selection. J. Virol. 69:7314-7338
9. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles to success. J. Biol. Chem. 270:404-410.
10. Cunliffe, V., D. Thatcher, and R. Craig. 1995. Innovative approach to gene therapy. Curr. Opin. Biotechnol. 6:709-713.
11. Davis, M. D., R. S. Wonderling, S. L. Walker, and R. A. Owens. 1999. Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro. J. Virol. 73:2084-2093.
12. Di Pasquale, G., and S. N. Stacey. 1998. Adeno-associated virus Rep78 protein interacts with protein kinase A and its homologue PRKX and inhibits CREB-dependent transcriptional activation. J. Virol. 72:7916-7925.
13. Evan, G. I., and G. K. Lewis. 1985. Isolation of monolonal antibodies specific for c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616.
14. Flotte, T. R., and B. J. Carter. 1995. Adeno-associated virus vectors for gene therapy. Gene Ther. 2:357-362.
15. Giraud, C., E. Winocour, and K. I. Berns. 1994. Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc. Natl. Acad. Sci. USA 91:10039-10043.
16. Guiochon-Mantel, A., H. Loosfelt, P. Lescop, S. Sar, M. Atger, M. Perrot-Applanat, and E. Milgrom. 1989. Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell 57:1147-1154.
17. Heilbronn, R., A. Bürkle, S. Stephan, and H. zur Hausen. 1990. The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J. Virol. 64:3012-3018.
18. Hermonat, P. L. 1991. Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product. Cancer Res. 51:3373-3377.
19. Hermonat, P. L. 1994. Down-regulation of the human c-fos and c-myc proto oncogene promoters by adeno-associated virus Rep78. Cancer Lett. 81:129-136.
20. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
21. Hörer, M., S. Weger, K. Butz, K. Hoppe-Seyler, C. Geisen, and J. A. Klein-Schmidt. 1995. Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J. Virol. 69:5485-5496.
22. Im, D.-S., and N. Muzyczka. 1990. The AAV origin-binding protein Rep68 is an ATP dependent site-specific endonuclease with DNA helicase activity. Cell 61:447-457.
23. Im, D.-S., and N. Muzyczka. 1992. Partial purification of adeno-associated virus Rep78, Rep68, Rep52, and Rep40 and their biochemical characterization. J. Virol. 66:1119-1128.
24. Kearns, W. G., S. A. Afione, S. B. Fulmer, M. G. Pang, D. Erikson, M. Egan, M. J. Landrum, T. R. Flotte, and G. R. Cutting. 1996. Recombinant adeno-associated (AAV-CTFR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3:748-755.
25. Kellendonk, C., F. Tronche, A.-P. Monaghan, P.-O. Angrand, K. Stewart, and G. Schütz. 1996. Regulation of Cre recombinase activity by the synthetic steroid RU486. Nucleic Acids Res. 24:1404-1414.
26. Kotin, R. M., M. Siniscalco, R. J. Samulski, X. D. Zhu, L. Hunter, C. A. Laughlin, S. M. Laughlin, N. Muzyczka, M. Rocchi, and K. I. Berns. 1990 Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87:2211-2215.
27. Kotin, H. M., R. M. Linden, and K. I. Berns. 1992. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11:5071-5078.
28. Kunar Tyagi, R., L. Amazit, P. Lescop, E. Milgrom, and A. Guiochon-Mantel. 1998. Mechanisms of progesterone receptor export from nuclei: role of nuclear localization signa, nuclear export signal, and Ran guanosine triphosphate. Mol. Endocrinol. 12:1684-1685.
29. Kyöstiö, S. R. M., R. S. Wonderling, and R. Owens. 1995. Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 Rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J. Virol. 69:6787-6796.
30. Lamartina, S., G. Roscilli, D. Rinaudo, P. Delmastro, and C. Toniatti. 1998. Lipofection of purified adeno-associated virus Rep68 protein: toward a chromosome targeting nonviral particle. J. Virol. 72:7653-7658.
31. Linden, R. M., and K. I. Berns. 1997. Site-specific integration by adeno-associated virus, a basis for a potential gene-therapy vector. Gene Ther. 4:4-5.
32. Linden, R. M., E. Winocour, and K. I. Berns. 1996. The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. USA 93:7966-7972
33. Linden, R. M., P. Ward, C. Giraud, E. Winocour, and K. I. Berns. 1996. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 93:11288-11294.
34. McCarty, D. M., T. H. Ni, and N. Muzyczka. 1912. Analysis of mutations in adeno-associated virus Rep protein in vivo and in vitro. J. Virol. 66:4050-41157.
35. Nichols, M., J. M. J. Rientjes, C. Logie, and A. F. Stewart. 1997. FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, hut not agonists. Mol. Endocrinol. 11:950-961.
36. Oñate, S. A., S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
37. Owens, R. A., M. D. Weitzman, S. R. M. Kyöstio, and B. J. Carter. 1993. Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins. J. Virol. 67:997-1005.
38. Palombo, F., A. Monciotti, A. Recchia, R. Cortese, G. Ciliberto, and N. La Monica. 1998. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J. Virol. 72:5025-5034.
39. Pereira, D. J., D. M. McCarty, and N. Muzyczka. 1997. The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J. Virol. 71:1079-1088.
40. Picard, D, S. J. Salser, and K. R. Yamamoto. 1988. A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell 54:1073-1080.
41. Picard, D. 1993. Steroid-binding domains for regulating the functions of heterologous proteins in cis. Trends Cell. Biol. 3:278-280.
42. Recchia, A., R. J. Parks, S. Lamartina, C. Toniatti, L. Pieroni, F. Palombo, G. Ciliberto, F. L. Graham, R. Cortese, N. La Monica, and S. Colloca. 1999. Site-specific integration mediated by a hybrid adenovirus/adenoassociated virus vector. Proc. Natl. Acad. Sci. USA 96:2615-2620.
43. Rizzuto, G., B. Gorgoni, M. Cappelletti, D. Lazzaro, I. Gloaguen, V. Poli, A. Sgura, D. Cimini, G. Ciliberto, R. Cortese, E. Fattori, and N. La Monica. 1999. Development of animal models for adeno-associated virus site-specific integration. J. Virol. 73:2517-2526.
44. Samulski, R. J. 1993. Adeno-associated virus: integration at a specific chromosomal locus. Curr. Opin. Genet. Dev. 3:74-80.
45. Samulski, R. J., L. S. Chang, and T. Shenk. 1987. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study in vitro replication. J. Virol. 61:3096-3101.
46. Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein, and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950. (Erratum, 11:1228, 1992.)
47. Shelling, A. N., and M. G. Smith. 1994. Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycine resistance gene. Gene Ther. 1:165-169.
48. Snyder, R. O., D-S. Im, T. Ni, X. Xiao, R. J. Samulski, and N. Muzyczka. 1993. Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein. J. Virol. 67:6096-6104.
49. Smith, D. F. 1993. Dynamics of heat shock protein 90-progesterone receptor binding and the disactivation loop model for steroid receptor complexes. Mol. Endocrinol. 7:1418-1429.
50. Spitkovsky, D., P. Steiner, J. Lukas, E. Lees, M. Pagano, A. Schultze, S. Joswig, D. Piccard, M. Tommasino, M. Eilers and P. Jansen-Dürr. 1994. Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation. 1994. J. Virol. 68:2206-2214.
51. Srivastava, A., E. W. Lusby, and K. I. Berns. 1983. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45:555-564.
52. Surosky, R. T., M. Urabe, S. G. Godwin, S. A. McQuiston, G. J. Kurtzman, K. Ozawa, and G. Natsoulis. 1997. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 71:7951-7959.
53. Triezenberg, S. J., R. C. Kingsbury and S. L. McKnight. 1998. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev. 2:718-729.
54. Tsai, M-J and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63: 451-486.
55. Urabe, M., Y. Hasumi, A. Kume, R. T. Surosky, G. J. Kurtzman, K. Tobita, and K. Ozawa. 1999. Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein. J. Virol. 73: 2682-2693.
56. Urcelay, E., P. Ward, S. M. Wiener, B. Safer, and R. M. Kotin. 1995. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol. 69:2038-2046.
57. Vegeto, E., G. F. Allan, W. T. Schrader, M-J. Tsai, D. P. McDonnell and B. W. O'Malley. 1992. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69:703-713.
58. Walker, S. L., R. S. Wonderling, and R. A. Owens. 1997. Mutational analysis of the adeno-associated virus Rep68 protein: identification of critical residues necessary for site-specific endonuclease activity. J. Virol. 71:2722-2730.
59. Wang, Y., B. W. O'Malley, Jr, S. Y. Tsai, and B. W. O'Malley. 1994. A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91:8180-8184.
60. Weitzman, M. D., S. R. Kyöstiö, R. M. Kotin, and R. A. Owens. 1994 Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA 91:5808-5812.
61. Weitzman, M. D., S. R. M. Kyöstiö, B. Carter, and R. A. Owens. 1996. Interaction of wild-type and mutant adeno-associated virus (AAV) rep proteins on AAV hairpin DNA. J. Virol. 70:2440-2448.
62. Wobbe, C. R., F. Dean, L. Weissbach, and J. Hurwitz. 1985. In vitro replication of duplex circular DNA containing the simian virus 40 DNA origin site. Proc. Natl. Acad. Sci. USA 82:5710-5714.
63. Wonderling, R. S., and R. Owens. 1996. The Rep68 protein of adeno-associated virus type 2 stimulates expression of the platelet-derived growth factor B c-sis proto-oncogene. J. Virol. 70:4783-4786.
64. Xu, L., C. K. Glass, and M. Rosenfeld. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Cell Biol. 9:140-147.
65. Yang, C. C., X. Xiao, X. Zhu, D. C. Ansardi, N. D. Epstein, M. R. Frey, A. G. Matera, and R. J. Samulski. 1997. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71:9231-9247.
66. Yang, Q., A. Kadam, and J. P. Trempe. 1992. Mutational analysis of the adeno-associated virus rep gene. J. Virol. 66:6058-6069.
67. Yang, Q., and J. P. Trempe. 1993. Analysis of the terminal repeat binding abilities of mutant adeno-associated virus replication proteins. J. Virol. 67: 4442-4447.
68. Yang, Q., C. Fan, and J. P. Trempe. 1994. Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J. Virol. 68:4847-4856.
69. Ylikomi, T., M. T. Bocquel, M. Berry, H. Gronmeyer, and P. Chambon. 1992. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J. 11:3681-3694.